RhoA stimulates IEC-6 cell proliferation by increasing polyamine-dependent Cdk2 activity

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 4 48-4, 2003, Pages

  Guo, Huazhang ^a   Ray, Ramesh M ^a   Johnson, Leonard R ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cyclin dependent kinase; Extracellular regulated kinase 1 2; Intestinal epithelial cells; Ornithine decarboxylase inhibition; p21Waf1 Cip1; p53; Putrescine; Transformation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; ORNITHINE DECARBOXYLASE INHIBITOR; PROTEIN P21; PROTEIN P53; PUTRESCINE; RHO KINASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC TRANSFECTION; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MESSENGER RNA SYNTHESIS; NEUROTRANSMITTER RELEASE; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

EID: 0141813345     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00044.2003     Document Type: Article

References (40)

1. (waf1) promoter by hepatitis B virus X protein via a p53-independent pathway. Gene 275: 163-168, 2001.
2. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, and Walter P. The cell cycle and programmed cell death. In: Molecular Biology of the Cell. New York: Garland Science, 2002, p. 983-1026.
3. Avraham H. Rho gene amplification and malignant transformation. Biochem Biophys Res Commun 168: 114-124, 1990.
4. Avraham H and Weinberg RA. Characterization and expression of the human rhoH12 gene product. Mol Cell Biol 9: 2058-2066, 1989.
5. Brondello JM, McKenzie FR, Sun H, Tonks NK, and Pouyssegur J. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10: 1895-1904, 1995.
6. Cotran RS, Kumar V, and Collins T. Robbins pathologic basis of disease. In: Robbins Pathologic Basis of Disease (6th ed.). Philadelphia, PA: Saunders, 1999, p. 260-328.
7. Danesh FR, Sadeghi MM, Amro N, Philips C, Zeng L, Lin S, Sahai A, and Kanwar YS. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc Natl Acad Sci USA 99: 8301-8305, 2002.
8. DeSilva DR, Jones EA, Favata MF, Jaffee BD, Magolda RL, Trzaskos JM, and Scherle PA. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent allergy. J Immunol 160: 4175-4181, 1998.
9. Dudley DT, Pang L, Decker SJ, Bridges AJ, and Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92: 7686-7689, 1995.
10. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, and Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998.
11. Fritz G, Just I, and Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer 81: 682-687, 1999.
12. Frost JA, Geppert TD, Cobb MH, and Feramisco JR. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci USA 91: 3844-3848, 1994.
13. Geng Y and Weinberg RA. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90: 10315-10319, 1993.
14. Haapajarvi T, Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang XF, and Laiho M. UV radiation is a transcriptional inducer of p21 (Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner. Exp Cell Res. 248: 272-279, 1999.
15. Horiguchi-Yamada J, Yamada H, Nakada S, Ochi K, and Nemoto T. Changes of G1 cyclins, Cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA. Mol Cell Biochem 132: 31-37, 1994.
16. Kamai T, Arai K, Tsujii T, Honda M, and Yoshida K. Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int 87: 227-231, 2001.
17. Li L, Liu L, Rao JN, Esmaili A, Strauch ED, Bass BL, and Wang JY. JunD stabilization results in inhibition of normal intestinal epithelial cell growth through p21 after polyamine depletion. Gastroenterology 123: 764-779, 2002.
18. Liberto M, Cobrinik D, and Minden A. Rho regulates p21 (CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 21: 1590-1599, 2002.
19. Liu G, Xia T, and Chen X. The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein. J Biol Chem 278: 17557-17565, 2003.
20. Love RR, Jacoby R, Newton MA, Tutsch KD, Simon K, Pomplun M, and Verma AK. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev 7: 989-992, 1998.
21. Marton LJ and Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55-91, 1995.
22. McMahon SB and Monroe JG. Role of primary response genes in generating cellular responses to growth factors. FASEB J 6: 2707-2715, 1992.
23. Meloche S, Seuwen K, Pages G, and Pouyssegur J. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol Endocrinol 6: 845-854, 1992.
24. Meyskens FL Jr, Emerson SS, Pelot D, Meshkinpour H, Shassetz LR, Einspahr J, Alberts DS, and Gerner EW. Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 86: 1122-1130, 1994.
25. Olson MF, Paterson HF, and Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/ Cip1. Nature 394: 295-299, 1998.
26. Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, and Pouyssegur J. Mitogen-activated protein kinases p42 MAPK and p44 MAPK are required for fibroblast proliferation. Proc Natl Acad Sci USA 90: 8319-8323, 1993.
27. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48: 759-774, 1988.
28. Prados M, Rodriguez L, Chamberlain M, Silver P, and Levin V. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine. Neurosurgery 24: 806-809, 1989.
29. Qiu RG, Chen J, McCormick F, and Symons M. A role for Rho in Ras transformation. Proc Natl Acad Sci USA 92: 11781-11785, 1995.
30. Quaroni A, Wands J, Trelstad RL, and Isselbacher KJ. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80: 248-265, 1979.
31. Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, and Reddy BS. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res 51: 4528-4534, 1991.
32. Ray RM, McCormack SA, and Johnson LR. Polyamine depletion arrests growth of IEC-6 and Caco-2 cells by different mechanisms. Am J Physiol Gastrointest Liver Physiol 281: G37-G43, 2001.
33. Ray RM, Patel A, Viar MJ, McCormack SA, Zheng Y, Tigyi G, and Johnson LR. RhoA inactivation inhibits cell migration but does not mediate the effects of polyamine depletion. Gastroenterology 123: 196-205, 2002.
34. Ray RM, Zimmerman BJ, McCormack SA, Patel TB, and Johnson LR. Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. Am J Physiol Cell Physiol 276: C684-C691, 1999.
35. Reddy BS, Nayini J, Tokumo K, Rigotty J, Zang E, and Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-α -difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 50: 2562-2568, 1990.
36. Sahai E, Olson MF, and Marshall CJ. Cross-talk between Ras and Rho signalling pathways in transformation favors proliferation and increased motility. EMBO J 20: 755-766, 2001.
37. Self AJ, Paterson HF, and Hall A. Different structural organization of Ras and Rho effector domains. Oncogene 8: 655-661, 1993.
38. Sherr CJ and Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
39. Silen W. Gastric mucosal defense and repair. In: Physiology of the Gastrointestinal Tract (2nd ed.), edited by Johnson LR. New York: Raven, 1987, p. 1055-1069.
40. Tabor CW and Tabor H. Polyamines. Annu Rev Biochem 53: 749-790, 1984.